HomeCompareSIVBP vs JNJ

SIVBP vs JNJ: Dividend Comparison 2026

SIVBP yields 8.60% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIVBP wins by $5.1K in total portfolio value
10 years
SIVBP
SIVBP
● Live price
8.60%
Share price
$15.23
Annual div
$1.31
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.3K
Annual income
$1,480.72
Full SIVBP calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SIVBP vs JNJ

📍 SIVBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIVBPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIVBP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SIVBP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIVBP
Annual income on $10K today (after 15% tax)
$731.12/yr
After 10yr DRIP, annual income (after tax)
$1,258.61/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $2,727.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIVBP + JNJ for your $10,000?

SIVBP: 50%JNJ: 50%
100% JNJ50/50100% SIVBP
Portfolio after 10yr
$32.8K
Annual income
$3,085.06/yr
Blended yield
9.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SIVBP
Analyst Ratings
15
Buy
15
Hold
Consensus: Buy
Altman Z
0.3
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIVBP buys
0
JNJ buys
0
No recent congressional trades found for SIVBP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIVBPJNJ
Forward yield8.60%2.13%
Annual dividend / share$1.31$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$35.3K$30.3K
Annual income after 10y$1,480.72$4,689.40
Total dividends collected$11.7K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SIVBP vs JNJ ($10,000, DRIP)

YearSIVBP PortfolioSIVBP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,560$860.14$10,592$272.30+$968.00SIVBP
2$13,299$929.29$11,289$357.73+$2.0KSIVBP
3$15,229$999.11$12,123$472.89+$3.1KSIVBP
4$17,364$1,069.26$13,141$629.86+$4.2KSIVBP
5$19,719$1,139.42$14,408$846.81+$5.3KSIVBP
6$22,308$1,209.30$16,021$1,151.60+$6.3KSIVBP
7$25,149$1,278.61$18,122$1,588.22+$7.0KSIVBP
8$28,256$1,347.10$20,930$2,228.20+$7.3KSIVBP
9$31,649$1,414.54$24,792$3,191.91+$6.9KSIVBP
10$35,345$1,480.72$30,274$4,689.40+$5.1KSIVBP

SIVBP vs JNJ: Complete Analysis 2026

SIVBPStock

SVB Financial Group, a diversified financial services company, offers various banking and financial products and services. It operates through four segments: Global Commercial Bank, SVB Private Bank, SVB Capital, and SVB Securities. The Global Commercial Bank segment provides commercial banking products and services, including credit, treasury management, foreign exchange, trade finance, and other financial products and services. This segment also offers traditional term and equipment loans, asset-based loans, revolving lines of credit, warehouse facilities, recurring revenue and acquisition finance facilities, mezzanine lending, corporate working capital facilities, and credit card programs; treasury management products and services; business and analysis checking, money market, multi-currency, in-country bank, and sweep accounts; receivables services, which include merchant services, remote capture, lockbox, and fraud control services; wire transfer and automated clearing house payment services; business bill pay, credit and debit cards, account analysis, and disbursement services. In addition, it offers foreign exchange and trade finance products and services; letters of credit; and investment services and solutions. The SVB Private Bank segment offers mortgages, home equity lines of credit, restricted and private stock loans, capital call lines of credit, and other secured and unsecured lending products; planning-based financial strategies, wealth management, family office, financial planning, tax planning, and trust services; and real estate secured loans. The SVB Capital segment provides venture capital investment services. The SVB Securities segment provides investment banking services; products and services, including capital raising, merger and acquisition advisory, equity research, and sales and trading. It operates through 56 offices in the United States and internationally. The company was founded in 1983 and is headquartered in Santa Clara, California.

Full SIVBP Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SIVBP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIVBP vs SCHDSIVBP vs JEPISIVBP vs OSIVBP vs KOSIVBP vs MAINSIVBP vs ABBVSIVBP vs MRKSIVBP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.